| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 835 | 2022 |
| Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy GL Dean, SG Edwards, NJ Ives, G Matthews, EF Fox, L Navaratne, ... Aids 16 (1), 75-83, 2002 | 554 | 2002 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 513 | 2021 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 461 | 2019 |
| Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men T van de Laar, O Pybus, S Bruisten, D Brown, M Nelson, S Bhagani, ... Gastroenterology 136 (5), 1609-1617, 2009 | 430 | 2009 |
| Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label … JK Rockstroh, M Nelson, C Katlama, J Lalezari, J Mallolas, M Bloch, ... The lancet HIV 2 (8), e319-e327, 2015 | 408 | 2015 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 372 | 2021 |
| Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection TJ Van De Laar, GV Matthews, M Prins, M Danta Aids 24 (12), 1799-1812, 2010 | 365 | 2010 |
| Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018 | 323 | 2018 |
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy S Collins, M Fisher, M Johnson, S Khoo, C Leen, C Loveday, G Moyle, ... | 283 | 2003 |
| Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy GV Matthews, M Bower, S Mandalia, T Powles, MR Nelson, BG Gazzard Blood, The Journal of the American Society of Hematology 96 (8), 2730-2734, 2000 | 259 | 2000 |
| Potential role for Interleukin‐28B genotype in treatment decision‐making in recent hepatitis C virus infection J Grebely, K Petoumenos, M Hellard, GV Matthews, V Suppiah, ... Hepatology 52 (4), 1216-1224, 2010 | 248 | 2010 |
| An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ... Aids 17 (1), F7-F10, 2003 | 233 | 2003 |
| Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy GV Matthews, A Bartholomeusz, S Locarnini, A Ayres, J Sasaduesz, ... Aids 20 (6), 863-870, 2006 | 228 | 2006 |
| Sexually transmitted hepatitis C infection: the new epidemic in MSM? D Bradshaw, G Matthews, M Danta Current opinion in infectious diseases 26 (1), 66-72, 2013 | 188 | 2013 |
| Effective treatment of injecting drug users with recently acquired hepatitis C virus infection GJ Dore, M Hellard, GV Matthews, J Grebely, PS Haber, K Petoumenos, ... Gastroenterology 138 (1), 123-135. e2, 2010 | 178 | 2010 |
| A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand GV Matthews, A Avihingsanon, SR Lewin, J Amin, R Rerknimitr, ... Hepatology 48 (4), 1062-1069, 2008 | 171 | 2008 |
| Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study GV Matthews, CA Sabin, S Mandalia, F Lampe, AN Phillips, MR Nelson, ... Aids 16 (1), 53-61, 2002 | 164 | 2002 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 155 | 2022 |
| Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection J Grebely, ST Pham, GV Matthews, K Petoumenos, RA Bull, B Yeung, ... Hepatology 55 (4), 1058-1069, 2012 | 145 | 2012 |
